Brendan Smith
Stock Analyst at TD Cowen
(1.71)
# 3,398
Out of 5,147 analysts
16
Total ratings
45.45%
Success rate
0.47%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $6.75 | +77.78% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $46.92 | -8.35% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $12.23 | +55.36% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $12.06 | +99.00% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $4.48 | +11.61% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $26.98 | +44.55% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $69.53 | +29.44% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $10.14 | -30.97% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $254.34 | +37.61% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $63.27 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.18 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $6.75
Upside: +77.78%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $46.92
Upside: -8.35%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $12.23
Upside: +55.36%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $12.06
Upside: +99.00%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.48
Upside: +11.61%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $26.98
Upside: +44.55%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $69.53
Upside: +29.44%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $10.14
Upside: -30.97%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $254.34
Upside: +37.61%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $63.27
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $21.18
Upside: -